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Background: The incidence of invasive mycoses is increasing worldwide. PCR-RFLP was applied to the
identiﬁcation of 10 reference strains and 90 cultures of agents of invasive mycoses. In addition, the new
approach was applied to detect fungal agents in 120 biological samples (blood, cerebrospinal ﬂuid and bone
marrow). PCR-RFLP results were compared with the ones obtained with conventional methods (culture,
microscopy, and biochemical testing).
Results: The assays carried out with the reference strains (Candida albicans, Candida parapsilosis, Candida
tropicalis, Candida krusei, Candida guilliermondii, Cryptococcus neoformans, Cryptococcus gattii and Histoplasma
capsulatum), demonstrated that the RFLP proﬁles were correctly predicted by the in silico investigation and
allowed unequivocal identiﬁcation of all chosen reference strains. The PCR-RFLP also identiﬁed 90 cultures of
agents of invasive mycoses correctly, 2.5 times faster than the conventional assays. Evaluating PCR-RFLP with
biological samples it was observed that the PCR was found to be 100% accurate and the RFLP proﬁles allowed
the identiﬁcation of the etiological agents: C. neoformans (n = 3) and C. gattii (n = 1) in CSF samples, H.
capsulatum (n = 1) in bone marrow and C. albicans (n = 2) in blood cultures. The detection and identiﬁcation
by PCR-RFLP were found to be between two to ten times faster than the conventional assays.
Conclusion: The results showed that PCR-RFLP is a valuable tool for the identiﬁcation of invasivemycoses that can
be implemented in hospital laboratories, allowing for a high number of clinical analyses per day.© 2015 Pontiﬁcia Universidad Católica de Valparaíso. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
In recent years, the incidence of invasive mycoses has globally
increased rendering in an important cause of morbidity and mortality,
especially in immunocompromised patients, such as those having
acquired AIDS, transplant patients using corticosteroids and/or
patients undergoing chemotherapy in intensive care units [1,2,3]. Due
to the high morbidity and mortality, and a tendency to rapidly spread
to other organs, early diagnosis and a correct treatment of invasive
fungal infections are essential with sensitive and rapid diagnostics in
urgent need [4].
Currently, in developing countries including Brasil, the identiﬁcation
of invasive fungal infections comprises conventional culture,Católica de Valparaíso.
araíso. Production and hosting by Elbiochemical methods, microscopic determination of micromorphology
and immunological assays. However, these traditional methods
(culture and direct) are most often used to detect agents that cause
mycoses. The MALDI-TOF technique is being used as an alternative
to precocious identiﬁcation of fungal species; however, it is still not
a reality in Brasil [5,6]. To overcome these limitations, molecular
approaches can be used for the detection and identiﬁcation of
pathogenic fungi [7,8].
Methods employing polymerase chain reaction (PCR) are among
the most promising alternatives and are increasingly being applied
in routine detection of pathogenic microorganisms. The greatest
advantages of PCR can be seen in its sensitivity, speciﬁcity and speed
with test results being available within hours [9,10]. Real-Time PCR
and microarray assays have been investigated for the detection and
identiﬁcation of pathogenic fungi [11,12,13]. However, these methods
are the most of the time, unavailable in the routine of mycology
laboratories of developing countries.sevier B.V. All rights reserved.
Table 1
Sizes of PCR products of the ITS region 5 and DdeI restriction fragments based on nucleotide sequence deposited in GenBank.
Species Access number in NCIS-Gene Bank Product size and NL4 primers ITS5 Digestion products (DdeI)
C. albicans BD309277 1153 bp 440, 361, 212, 140 bp
C. tropicalis EU924133.1 1142 bp 435, 289, 212, 138, 68 bp
C. parapsilosis FJ746057 1137 bp 567, 284, 212, 68, 6 bp
C. krusei AB369918.1 1120 bp 556, 338, 200, 26pb
C. guilliermondii JX993815 1224 bp 419, 359, 235, 211 bp.
C. neoformans AF356652.1 1201 bp 602, 398, 104, 48, 49 bp
C. gattii JN939487.1 1561 bp 603, 538, 320, 32 bp
H. capsulatum AB436785.1 1239 bp 512, 432, 235, 60 bp
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from the fungi rDNA that was able to differentiate the most important
agents from invasive mycosis. The present work is the continuation
of the assessment of this study by applying it in the routine of
a hospital with patients at risk of being affected by invasive
mycosis. The Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
(FMT-HVD) is a reference hospital for the treatment of tropical
diseases in the North of Brasil. Its wards are mostly occupied by
immunocompromised patients with AIDS, who are highly susceptible
to infections with opportunistic pathogens.
2. Materials and methods
The study was conducted in three stages: a) PCR-RFLP (NL4-ITS5,
DdeI digestion) of reference strains; b) PCR-RFLP for identiﬁcation of
90 cultures of clinical isolates comparing the results with conventional
techniques; and c) determination of accuracy of PCR for detection and
RFLP for the identiﬁcation of causative agents of invasive mycoses
in biological samples from 120 patients with clinical suspicion of
invasive mycoses, prospectively. For the analysis of these latter, data
was supplemented with epidemiological characteristics of patients
with fungal infection.
2.1. Reference strains
The following fungal strains belonging to the collection of the
Instituto Nacional de Pesquisas da Amazônia (INPA) were used as
reference: Candida albicans FMT170, Candida parapsilosis FMT72,
Candida tropicalis FMT44, Candida krusei ATCC6258, Candida
guilliermondii ATCC6260, Cryptococcus neoformans FMT1420,
Cryptococcus gattii FMT1170 and Histoplasma capsulatum FMT1400.
2.2. Cultures of clinical isolates
90 cultures of causative agents of invasive mycosis were obtained
of the samples from patients with HIV/AIDS, referred to FMT-HVD inFig. 1. PCRdigestion productswithDdel. PCRproductswere obtained fromDNA isolated from st
C. krusei ATCC6258 (Ck), C. guilliermondii ATCC6260 (Cgui), C. neoformans FMT1420 (Cn), C. gathe period between December 2005 and January 2008, and March and
August 2012. These cultures were analyzed by conventional PCR and
the PCR-RFLP, simultaneously.
2.3. Biological samples
120 biological samples were investigated includingwhole blood (7),
blood culture (33), cerebrospinal ﬂuid (CFS) (70) and bone marrow
aspirate (10). Samples were taken from patients with suspected
invasive mycosis who had been referred to the Mycology Laboratory
of the FMT-HVD between September and December 2012, to the
realization the conventional PCR and RFLP. Anonymized information
of patients (sex, age, place of residence, clinical specimen investigated,
HIV serology, viral load of HIV and CD4+ cells/mm3) was obtained
from the computerized system “iDoctor hospital” used in FMT-HVD.
2.4. Detection and identiﬁcation by conventional methods
Cultivation of biological samples was performed on Agar Sabouraud
(BD Difco, Sparks, USA) and Agar Mycosel (BD Difco, Sparks, USA).
Colonies growing on Sabouraud agar were identiﬁed by standard
laboratory methods, including micro morphological and physiological
tests (germ tube production, growth on Agar Niger and CHROMagar™
Candida (Becton-Dickinson, Sparks, USA)), incubation at 42°C, and
testing for carbohydrate and nitrogen assimilation and carbohydrate
fermentation.
2.5. Detection and identiﬁcation by PCR-RFLP
Generation of PCR products and subsequent digestion was
performed as described by Santos et al. [14]. DNA was extracted from
samples (200 μL of fungal biomass or biological sample) using the
QIAamp Blood and Tissue kit (Qiagen, Hilden, Germany) following the
recommendations of the manufacturer. The DNA was quantiﬁed
by absorbance at 260 nm using Genequant (Eppendorf, Hamburg,
Germany) and 20 ng of the extracted DNA served as a template forandard strains: C. albicans (Ca) FMT170, C. parapsilosis (Cp) FMT72, C. tropicalis (Ct) FMT44,
ttii FMT1170 (Cga) and ss FMT1400 (Hc).
Table 3
Epidemiological characteristics of patients with false positive PCR diagnosis.
No Pac Age Gender Manaus area HIV C. Viral HIV
cop/mL
Linf. CD4
cells/mL
Sample
28 38 F West Positive 7.135 171 CSF
33 40 M East Positive 40.759 131 CSF
50 34 M East Positive b50 384 CSF
53 49 F East Positive b50 289 CSF
59 63 M East Positive 23.587 65 CSF
71 38 F East Positive 36.146 226 CSF
78 54 F East Positive 11.367 10 CSF
80 59 M East Positive 43.601 160 CSF
97 45 M East Positive b50 307 CSF
99 39 F East Positive 1.551 282 CSF
105 41 M East Positive 3.670 376 CSF
117 48 M North Positive 32.609 250 CSF
Table 2
Sensibility and speciﬁcity between PCR (ITS5-NL4) and conventional methods for the
detection of fungi in 120 biological samples.
Culture
Positive Negative
PCR Positive 7 12
Negative 0 101
Sensibility 100%
Speciﬁcity 89.4%
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PCR buffer (ﬁnal concentration: 1 ×10mMTris–HCl, pH 8.3, 50mMKCl);
1.5 mM MgCl2; 200 nM primers ITS5 (5′-GGAAGTAAAAGTCGTAACAA
GG-3) and NL4 (5′-GGTCCGTGTTTCAAGACGG-3′; both primers were
described by Irobi et al. [15]), 50 μM dNTPs, and 1 U Ampli-Taq DNA
polymerase.
PCR was performed using a thermocycler (Kyratec's SuperCycle,
Republic of Korea) under the following PCR conditions: initial
denaturation of 5 min at 94°C, 40 cycles of 30 s at 94°C
(denaturation), 30 s at 50°C (annealing), for 30 s and 1 min at 72°C
(extension), followed by a ﬁnal extension for 10 min at 72°C. PCR
products were visualized by electrophoresis on a 2% agarose gel and
stained with SYBR® Green (SYBR Safe DNA Gel Stain, Invitrogen,
Carlsbad, USA). A DNA Ladder Mix of 100 bp (SM0331, MBI
Fermentas, St. Leon-Rot, Germany) served as size marker. For RFLP,
PCR products from individual isolates were digested with 10 U of the
restriction enzyme DdeI (Thermo Fisher Scientiﬁc, Vilnius, Lithuania)
for 3 h at 37°C, and subjected to electrophoresis as described above.
The sizes of the PCR products and restriction fragments generated
from the isolates were compared with the corresponding nucleotide
sequences deposited in the GenBank database (Table 1).
2.6. In silico evaluations
National Center for Biotechnology Information (NCBI) sequences
were subjected to in silico restriction digestion utilizing the BLAST
package (http://www.ncbi.nlm.nih.gov/BLAST). The BioEdit software
(http://jwbrown.mbio.ncsu.edu/BioEdit/bioedit.html) was used for
editing and aligning the sequences.
3. Results
3.1. PCR-RFLP's proﬁles obtained with the reference strains
Eight reference strains were submitted to PCR-RFLP in order
to investigate if the proﬁles described in silico (Table 1) were similar
to that obtained experimentally. As shown in Fig. 1, the PCR-RFLP
proﬁles were correctly predicted by the in silico investigation. In
addition, RFLP patterns distinct all chosen reference strains allowing
their unequivocal identiﬁcation.
3.2. PCR-RFLP's proﬁles obtained with cultures from clinical isolates
PCR-RFLP was evaluated for identifying cultures obtained in
the routine of a healthcare facility in the North of Brasil, 90 clinical
cultures of fungi previously isolated from clinical samples were
investigated. These same cultures were also submitted for
identiﬁcation by conventional methods (phenotypic assays). It was
observed 100% accordance with the conventional and PCR-RFLP
identiﬁcation. Both methods take, on average, 5 and 2 d, respectively.
3.3. PCR (NL4-ITS5) sensibility/speciﬁcity and PCR-RFLP's identiﬁcation of
fungal agents in biological samples
PCR-RFLP was also evaluated for the detection/identiﬁcation of
fungal agents directly in biological samples. It was carried out an
accuracy study comparing both the PCR-RFLP and conventional
methods. 120 biological samples were assessed, including whole
blood (7), blood culture (33), CFS (70) and bone marrow aspirate (10).
Seven biological samples were considered positive by conventional
methods. None of these culture-positive results was PCR-negative
corresponding to a 100% sensibility (Table 2). On the other hand, 12
samples were considered positive only by PCR but tested negative by
conventional methods. In addition, to the high sensitivity, PCR-RFLP
took only two days while the conventional identiﬁcation tookbetween 3 and 25 d (with an average of 5 d), for the fungal agents
identiﬁcation.
All the 12 patients considered positive only by PCR had been
previously diagnosed with cryptococcosis and submitted to an
antifungal treatment against cryptococcal meningitis (Table 3). The
digestion of the PCR products allowed the identiﬁcation of C.
neoformans in all these 12 samples.
The seven patients diagnosed by both (conventional and PCR
methods) were mostly men (n = 5); age range between 18 and 58
and the majority of them lived in the East Zone of Manaus. Five
of them were HIV positive presenting viral loads between b50
to 170,660 copies/mL and lymphocytes CD4+ between 5 and
491 cells/mL. The RFLP patterns allowed identifying their fungal
agents as C. neoformans (n = 3) in CSF samples, C. gattii (n = 1) in
CSF sample, H. capsulatum (n = 1) in a sample of bone marrow and C.
albicans (n = 2) in blood cultures. The conventional assays and
PCR-RFLP showed identical species identiﬁcations (Table 4).4. Discussion
The present study demonstrated that PCR-RFLP is a useful tool for
routine detection and identiﬁcation of agents of invasive mycoses in a
tertiary healthcare facility in the state of Amazonas-Brazil. It was
observed that: a) the products of PCR and RFLP proﬁles obtained with
the standard strains were similar to those achieved with the in silico
assays; b) all cultures of 90 clinical isolates were identically identiﬁed
by conventional methods and PCR-RFLP; and c) the application of PCR
(ITS4-NL5) to investigate the fungi detection directly in biological
samples resulted in 100% sensitivity and the RFLP proﬁles allowed
correct identiﬁcation of the causative agents. Whereas the majority of
previously published works were limited to identiﬁcation of standard
strains and cultures of clinical isolates, this study demonstrates the
effective detection and identiﬁcation of fungi by PCR-RFLP directly
from clinical samples of biological origin.
The PCR-RFLP assay can be useful for laboratories that do not have
real-time thermocycling capability. PCR-RFLP is a simple molecular
Table 4
Epidemiological characteristics of patients with true positive PCR diagnosis.
No Pac Age Gender Manaus area HIV C. Viral HIV
cop/mL
Linf. CD4
cells/mL
Sample Identiﬁcation by conventional culture and PCR-RLFP
01 34 F North Positive b50 238 CSF C. neoformans
17 18 M East Negative 102 203 CSF C. gatti
40 58 F East Positive b50 174 Blood culture C. albicans
47 25 M North Negative 170.660 151 Bone marrow H. capsulatum
48 28 M East Negative b50 167 Blood culture C. albicans
56 18 M East Positive 45.525 5 CSF C. neoformans
77 31 M East Positive 1.449 34 CSF C. neoformans
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provides results suitable for the simultaneous analysis of several species
[14,15].
RFLP proﬁles obtained with the standard strains investigated in this
work (Fig. 1) were consistent with the results predicted theoretically
and in practice found by Santos et al. [14], Irobi et al. [15], Fallahi et al.
[16], and Kordbacheh et al. [17]. There are a vast number of other
fungal species that can cause invasive mycosis and that are not
considered by the method described. Therefore, data must be
analyzed with caution due to the risk of misdiagnosis.
In regard to conventional identiﬁcation of cultures of invasive
mycoses agents, it should be mentioned that the identiﬁcation of
Candida spp. uses enzymes, assimilation and fermentation trials. It is
expensive when performed with commercial kits and slow when
performed without them. The identiﬁcation of Cryptococcus spp. is
possible using the culture medium canavanine glycine bromothymol
blue agar (CGB), however, test results are only obtained after
an average of 3 d, and are subject to error. The identiﬁcation of
H. capsulatum is undoubtedly the most time consuming with
cultivation requiring, on average 25 d to develop visible growth.
Subsequent identiﬁcation is micro morphological, conﬁrmatory
assay identiﬁcation (pleomorphism test) may take over 25 d [7,8,18].
An attractive possibility for the use of PCR-RFLP, therefore, consists in
the identiﬁcation of colonies obtained from clinical samples. The
method allows the establishment of a database containing RFLP
proﬁles from relevant microorganisms. The identiﬁcation of 90 fungal
cultures isolated from clinical specimens presenting results similar to
the results of conventional methods demonstrates this statement.
Regarding the use of PCR (NL4-ITS5) for detecting agents that cause
invasivemycoses, thedata presented in this study conﬁrms that this test
has adequate sensitivity and can be used with biological materials from
different sources (blood, CSF and bone marrow).
This study also revealed that PCR detected C. neoformans in CFS
samples that were considered negative by the conventional methods.
Interestingly, all these samples were obtained from AIDS patients
having undergone antifungal therapy against cryptococcal meningitis.
This fact tempts to speculate that the CFS of these patients contained
dead fungal cells or residual DNA from previous infection causing
positive PCR results and explaining lack of success to culture the
pathogens. It remains to be assessed whether nucleic acids from
therapy-killed fungal cells remain intact longer in this highly sheltered
environment [19]. If so, the interpretation of PCR results obtained
from this type of clinical samples has to be interpreted with care and
always to observe that the control sample in this case was efﬁcient.
Elimination of this residual nucleic acid can be obtained by sample
treatment with viability dye, such as propidium monoazide might
overcome this limitation [20,21].Financial support
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